PAVEWAY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PAVEWAY Trademark

Serial Number: 79412046 • Registration: 7998538

PAVEWAY is a trademark filed by FUJIFILM Diosynth Biotechnologies UK Limited on August 28, 2024. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

FUJIFILM Diosynth Biotechnologies UK Limited

Belasis Avenue

Entity Type: 99

Trademark Details

Filing Date

August 28, 2024

Registration Date

October 28, 2025

Published for Opposition

September 9, 2025

Goods & Services

Chemicals used in industry and science; cell cultures used in industry and science; biological preparations for use in science; biological preparations for use in cell cultures, other than for medical or veterinary purposes; proteins for industrial use; microbial preparations being chemicals for industry; cultures of micro-organisms other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purpose; organic chemicals for use in science, namely genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for use in science; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry, other than for medical or veterinary use; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes.

Processing and manufacturing of chemicals and proteins; custom manufacture of chemicals and proteins for use in biotechnology and pharmaceuticals; manufacture, processing and production of scientific and industrial products, namely, recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services of chemicals and proteins; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid.

Scientific, industrial and technical research in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific analysis in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; technological analysis services in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific research and development; industrial process development in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; industrial design services; provision of facilities for scientific, industrial and technical research and development in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; research and development of scientific, industrial and technical products; technical project studies in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; testing of scientific, industrial and technical products in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific research, industrial research in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals and technical product research and development services in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; development of processes for use in the manufacture of pharmaceutical and biological products; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 28, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 28, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2026 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
May 10, 2026 FICS
FINAL DISPOSITION PROCESSED
May 10, 2026 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 28, 2026 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 16, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 26, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 10, 2025 RFRR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 12, 2025 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 5, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2024 REPR